Starling Oncology, Inc. (STLN) › Cash & EquivalentsStarling Oncology, Inc. (STLN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.Fiscal YearCash & EquivalentsChange YoY2020$900.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share